INGN
INGN
NASDAQ · Health Care

Inogen Inc

$5.37
-0.07 (-1.29%)
As of Sep 29, 10:12 PM ET ·
Financial Highlights (FY 2026)
Revenue
344.54M
Net Income
-22,478,036
Gross Margin
44.2%
Profit Margin
-6.5%
Rev Growth
-2.6%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 44.2% 44.2% 60.6% 60.6%
Operating Margin -8.7% -7.8% 10.4% 11.9%
Profit Margin -6.5% -6.2% 11.5% 10.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 344.54M 353.71M 69.91M 61.94M
Gross Profit 152.43M 156.48M 42.38M 37.55M
Operating Income -29,837,515 -27,567,768 7.24M 7.40M
Net Income -22,478,036 -20,768,126 8.03M 6.76M
Gross Margin 44.2% 44.2% 60.6% 60.6%
Operating Margin -8.7% -7.8% 10.4% 11.9%
Profit Margin -6.5% -6.2% 11.5% 10.9%
Rev Growth -2.6% -2.6% +4.1% -5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 9.00M 9.23M
Total Equity — — 58.44M 60.45M
D/E Ratio — — 0.15 0.15
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,988,447 -24,370,213 11.00M 10.83M
Free Cash Flow — — 6.40M 6.40M